These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9508062)

  • 1. Second 46,XX male with MLS syndrome.
    Stratton RF; Walter CA; Paulgar BR; Price ME; Moore CM
    Am J Med Genet; 1998 Feb; 76(1):37-41. PubMed ID: 9508062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another observation of microphthalmia in an XX male: microphthalmia with linear skin defects syndrome without linear skin lesions.
    Kono T; Migita T; Koyama S; Seki I
    J Hum Genet; 1999; 44(1):63-8. PubMed ID: 9929982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microphthalmia with linear skin defects syndrome.
    García-Rabasco A; De-Unamuno B; Martínez F; Febrer-Bosch I; Alegre-de-Miquel V
    Pediatr Dermatol; 2013; 30(6):e230-1. PubMed ID: 22612277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microphthalmia with linear skin defects syndrome (MLS): a male with a mosaic paracentric inversion of Xp.
    Kutsche K; Werner W; Bartsch O; von der Wense A; Meinecke P; Gal A
    Cytogenet Genome Res; 2002; 99(1-4):297-302. PubMed ID: 12900578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphthalmia with linear skin defects (MLS) syndrome evaluated by prenatal karyotyping, FISH and array comparative genomic hybridization.
    Cain CC; Saul D; Attanasio L; Oehler E; Hamosh A; Blakemore K; Stetten G
    Prenat Diagn; 2007 Apr; 27(4):373-9. PubMed ID: 17286317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphthalmia with linear skin defects (MLS) syndrome: clinical, cytogenetic, and molecular characterization.
    Lindsay EA; Grillo A; Ferrero GB; Roth EJ; Magenis E; Grompe M; Hultén M; Gould C; Baldini A; Zoghbi HY
    Am J Med Genet; 1994 Jan; 49(2):229-34. PubMed ID: 8116674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatoscopic aspects of the microphthalmia with linear skin defects (MLS) syndrome.
    Almeida HL; Rossi G; Abreu LB; Bergamaschi C; Silva AB; Kutsche K
    An Bras Dermatol; 2014; 89(1):180-1. PubMed ID: 24626674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterisation of a new case of microphthalmia with linear skin defects (MLS).
    Kayserili H; Cox TC; Cox LL; Basaran S; Kiliç G; Ballabio A; Yüksel-Apak M
    J Med Genet; 2001 Jun; 38(6):411-7. PubMed ID: 11424926
    [No Abstract]   [Full Text] [Related]  

  • 9. Mother and daughter with a terminal Xp deletion: implication of chromosomal mosaicism and X-inactivation in the high clinical variability of the microphthalmia with linear skin defects (MLS) syndrome.
    Wimplinger I; Rauch A; Orth U; Schwarzer U; Trautmann U; Kutsche K
    Eur J Med Genet; 2007; 50(6):421-31. PubMed ID: 17845869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microphthalmia with linear skin defects: a case report and review.
    Sharma VM; Ruiz de Luzuriaga AM; Waggoner D; Greenwald M; Stein SL
    Pediatr Dermatol; 2008; 25(5):548-52. PubMed ID: 18950397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia with linear skin defects syndrome in a mosaic female infant with monosomy for the Xp22 region: molecular analysis of the Xp22 breakpoint and the X-inactivation pattern.
    Ogata T; Wakui K; Muroya K; Ohashi H; Matsuo N; Brown DM; Ishii T; Fukushima Y
    Hum Genet; 1998 Jul; 103(1):51-6. PubMed ID: 9737776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome.
    van Rahden VA; Rau I; Fuchs S; Kosyna FK; de Almeida HL; Fryssira H; Isidor B; Jauch A; Joubert M; Lachmeijer AM; Zweier C; Moog U; Kutsche K
    Orphanet J Rare Dis; 2014 Apr; 9():53. PubMed ID: 24735900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xp22.3 microdeletion in a 19-year-old girl with clinical features of MLS syndrome.
    Enright F; Campbell P; Stallings RL; Hall K; Green AJ; Sweeney E; Barnes L; Watson R
    Pediatr Dermatol; 2003; 20(2):153-7. PubMed ID: 12657015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microphthalmia with linear skin defects (MLS) syndrome: familial presentation.
    Kumar P; Rajab A
    Clin Exp Dermatol; 2018 Mar; 43(2):196-197. PubMed ID: 29023962
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome.
    van Rahden VA; Fernandez-Vizarra E; Alawi M; Brand K; Fellmann F; Horn D; Zeviani M; Kutsche K
    Am J Hum Genet; 2015 Apr; 96(4):640-50. PubMed ID: 25772934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial cases of a submicroscopic Xp22.2 deletion: genotype-phenotype correlation in microphthalmia with linear skin defects syndrome.
    Vergult S; Leroy B; Claerhout I; Menten B
    Mol Vis; 2013; 19():311-8. PubMed ID: 23401659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of holocytochrome c-type synthetase causes the male lethality of X-linked dominant microphthalmia with linear skin defects (MLS) syndrome.
    Prakash SK; Cormier TA; McCall AE; Garcia JJ; Sierra R; Haupt B; Zoghbi HY; Van Den Veyver IB
    Hum Mol Genet; 2002 Dec; 11(25):3237-48. PubMed ID: 12444108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A very high density microsatellite map (1 STR/41 kb) of 1.7 Mb on Xp22 spanning the microphthalmia with linear skin defects (MLS) syndrome critical region.
    Cox TC; Cox LL; Ballabio A
    Eur J Hum Genet; 1998; 6(4):406-12. PubMed ID: 9781050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIDAS (microphthalmia, dermal aplasia, sclerocornea) syndrome with central nervous system abnormalities.
    Carman KB; Yakut A; Sabuncu I; Yarar C
    Clin Dysmorphol; 2009 Oct; 18(4):234-5. PubMed ID: 19726975
    [No Abstract]   [Full Text] [Related]  

  • 20. Corpus callosum agenesis, multiple cysts, skin defects, and subtle ocular abnormalities with a de novo mutation [45,XX,der(5), t(5;;14) (pter;q11.2)].
    Zannolli R; Mostardini R; Pucci L; Sorrentino L; Biagioli M; Perotti R; Guarna M; Hadjistilianou T; Zerega G; Pierluigi M; Franco B; D'Ambrosio A; Morgese G
    Am J Med Genet; 2001 Jul; 102(1):29-35. PubMed ID: 11471169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.